Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Yesafili 40 mg/ml Solution for injection in pre-filled syringe {equilateral_black_triangle}

Active Ingredient:
aflibercept
Company:  
Biocon Biologics See contact details
ATC code: 
S01LA05
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Yesafili BRVO Patient Guide

BRVO patient support guide

{pdf_link}

Yesafili CNV Patient Guide

mCNV Yesafili patient guide

{pdf_link}

Yesafili CRVO Patient Guide

CRVO Yesafili patient guide

{pdf_link}

Yesafili DMO Patient Guide

DMO Yesafili Patient support guide

{pdf_link}

Yesafili Prescriber Guide

{healthcare_pro_orange} For Healthcare Professionals

Yesafili Prescriber Guide

{pdf_link}

Yesafili wetAMD Patient Guide

wetAMD Yesafili patient guide

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Biocon Biologics
Company image
Address
16 Great Queen Street, Covent Garden, London, WC2B 5AH
Medical Information e-mail
[email protected]
Telephone
0080008250910